Hemab Therapeutics Holdings, Inc.
NASDAQCOAG enters the week with an unusual split: Wall Street initiated coverage with near-uniform bullishness just weeks ago, yet short sellers have been quietly building positions at a pace that stands out for such a newly covered name. The analyst picture is unambiguously constructive. Five firms initiated within weeks of each other, all with buy-equivalent ratings and targets…
COAG short interest
Full pulse commentary is for ORTEX subscribers. The live data picture for COAG below stays open — short interest, options flow, signals, and historical context.
Sign up free to read pulse →Short interest % of float, cost to borrow, utilization, and put/call ratio for COAG are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 18 Jun 2026
COAG enters the week with an unusual split: Wall Street initiated coverage with near-uniform bullishness just weeks ago, yet short sellers have been quietly building positions at a pace that stands out for such a newly…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COAG — free to start on ORTEX.
Sign up for free →Open COAG on ORTEX